The year 2020 has seen the emergence of the SARS-CoV-2 virus (COVID19), a unique and potentially devastating virus, with no known prevention or treatment. This new SARS-CoV-2 virus has shown to not only have significant international health implications, but also immense psychological and economic impacts. Associate Professor Nigel Crawford, a vaccinologist and consultant paediatrician at the Murdoch Children’s Research Institute (MCRI) & Royal Children’s Hospital (RCH), Melbourne, will delve into the global pursuit of a safe and effective vaccine to prevent COVID19. This is all occurring at ‘pandemic speed’ and MVEC’s new podcast will explore this complicated and multi-faceted process through interviews with a variety of national and international vaccine experts.
All content for COVID19 Road to a vaccine is the property of MVEC and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The year 2020 has seen the emergence of the SARS-CoV-2 virus (COVID19), a unique and potentially devastating virus, with no known prevention or treatment. This new SARS-CoV-2 virus has shown to not only have significant international health implications, but also immense psychological and economic impacts. Associate Professor Nigel Crawford, a vaccinologist and consultant paediatrician at the Murdoch Children’s Research Institute (MCRI) & Royal Children’s Hospital (RCH), Melbourne, will delve into the global pursuit of a safe and effective vaccine to prevent COVID19. This is all occurring at ‘pandemic speed’ and MVEC’s new podcast will explore this complicated and multi-faceted process through interviews with a variety of national and international vaccine experts.
The specific virus characteristics of SARS-CoV-2 with Professor Kanta Subbarao
COVID19 Road to a vaccine
30 minutes
5 years ago
The specific virus characteristics of SARS-CoV-2 with Professor Kanta Subbarao
In episode 4 of our COVID19 Road to a vaccine series, our host, Associate Professor Nigel Crawford, will be speaking to Professor Kanta Subbarao. Professor Subbarao has been the Director of the World Health Organisation Collaborating Centre for Reference and Research on Influenza since 2016, based at The Doherty Institute at the University of Melbourne, Australia. She is a virologist and physician who specialises in paediatric infectious diseases. Her research is focused on influenza, as well as newly emerging viral diseases of global importance such as SARS and MERS, which includes immune responses to infection and vaccination.
In this episode they discuss:
•The specific virus characteristics of SARS-CoV-2 •How the biosafety laboratory at VIDRL (Victorian Infectious Diseases Reference Laboratory) were able to culture the SARS-CoV-2 virus and distribute their findings globally •The origin of coronaviruses and why this pandemic strain is different •The spike protein and the important role antibodies play in the development of a SARS-CoV-2 vaccine •Immunological principles in the development of a SARS-CoV-2 vaccine •How to determine an antibody is functional and protective •The likelihood of SARS-CoV-2 changing over time
COVID19 Road to a vaccine
The year 2020 has seen the emergence of the SARS-CoV-2 virus (COVID19), a unique and potentially devastating virus, with no known prevention or treatment. This new SARS-CoV-2 virus has shown to not only have significant international health implications, but also immense psychological and economic impacts. Associate Professor Nigel Crawford, a vaccinologist and consultant paediatrician at the Murdoch Children’s Research Institute (MCRI) & Royal Children’s Hospital (RCH), Melbourne, will delve into the global pursuit of a safe and effective vaccine to prevent COVID19. This is all occurring at ‘pandemic speed’ and MVEC’s new podcast will explore this complicated and multi-faceted process through interviews with a variety of national and international vaccine experts.
